Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03021993
Title Trial of Nivolumab as a Novel Neoadjuvant Pre-Surgical Therapy for Locally Advanced Oral Cavity Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors David Neskey
Indications

oral squamous cell carcinoma

Therapies

Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.